» Articles » PMID: 38469251

The Effect of Positive Airway Pressure Therapy on Intraocular Pressure and Retina in Severe Obstructive Apnea Syndrome

Overview
Date 2024 Mar 12
PMID 38469251
Authors
Affiliations
Soon will be listed here.
Abstract

To identify and compare changes in intraocular pressure (IOP), macular, and peripapillary retinal nerve fiber layer (RNFL) thickness using optical coherence tomography (OCT) measurements before and after 3 months of positive airway pressure (PAP) therapy in patients with severe obstructive sleep apnea syndrome (OSAS). Twenty-five patients diagnosed with severe OSAS in the neurology sleep outpatient clinic were included in the study. Ophthalmologic examinations were performed at the time of diagnosis and after 3 months of PAP therapy. Statistical analysis of comparisons of pre-treatment and post-treatment measurements of IOP and OCT was performed. Before the PAP therapy, the correlations between central corneal thickness (CCT), body mass index (BMI), OCT, IOP, and sleep parameters were statistically analyzed. Compared to the pre-treatment measurements at the time of diagnosis, post-treatment measurements showed insignificant decrease in IOP, significant increase in mean macular thickness and significant thinning in superior nasal RNFL. There was no correlation found between pre-treatment measurements including IOP, OCT, CCT, BMI, and sleep parameters. The effect of intermittent hypoxia and hypercapnia on the IOP and macula may be reversible in severe OSAS patients receiving 3 months of PAP therapy, but the reversibility of the neurodegenerative effects of OSAS on RNFL with this treatment seems controversial. OCT can be considered to be a promising technique for monitoring disease progression under PAP therapy in patients with severe OSAS.

Citing Articles

Obstructive sleep apnoea and glaucoma: a systematic review and meta-analysis.

Cheong A, Wang S, Woon C, Yap K, Ng K, Xu F Eye (Lond). 2023; 37(15):3065-3083.

PMID: 36977937 PMC: 10564942. DOI: 10.1038/s41433-023-02471-6.

References
1.
Haefliger I, Dettmann E, Liu R, Meyer P, Prunte C, Messerli J . Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol. 1999; 43 Suppl 1:S51-8. DOI: 10.1016/s0039-6257(99)00026-0. View

2.
Krause B, Del Rio R, Moya E, Marquez-Gutierrez M, Casanello P, Iturriaga R . Arginase-endothelial nitric oxide synthase imbalance contributes to endothelial dysfunction during chronic intermittent hypoxia. J Hypertens. 2015; 33(3):515-24. DOI: 10.1097/HJH.0000000000000453. View

3.
McNicholas W, Bonsigore M, Bonsignore M . Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007; 29(1):156-78. DOI: 10.1183/09031936.00027406. View

4.
Dhillon S, Shapiro C, Flanagan J . Sleep-disordered breathing and effects on ocular health. Can J Ophthalmol. 2007; 42(2):238-43. DOI: 10.3129/can j ophthalmol.i07-029. View

5.
Geyer O, Cohen N, Segev E, Rath E, Melamud L, Peled R . The prevalence of glaucoma in patients with sleep apnea syndrome: same as in the general population. Am J Ophthalmol. 2003; 136(6):1093-6. DOI: 10.1016/s0002-9394(03)00709-8. View